Rafferty Asset Management LLC Has $13.34 Million Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Rafferty Asset Management LLC lifted its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 13.5% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 510,872 shares of the pharmacy operator’s stock after buying an additional 60,872 shares during the quarter. Rafferty Asset Management LLC’s holdings in Walgreens Boots Alliance were worth $13,339,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in WBA. Highlander Capital Management LLC acquired a new position in Walgreens Boots Alliance during the 4th quarter worth $26,000. Venturi Wealth Management LLC lifted its position in shares of Walgreens Boots Alliance by 1,241.8% during the 4th quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 981 shares during the last quarter. Rocky Mountain Advisers LLC bought a new stake in Walgreens Boots Alliance during the 4th quarter valued at approximately $30,000. Quest Partners LLC acquired a new stake in Walgreens Boots Alliance in the 4th quarter valued at approximately $30,000. Finally, Tyler Stone Wealth Management increased its position in Walgreens Boots Alliance by 1,280.0% in the 3rd quarter. Tyler Stone Wealth Management now owns 1,380 shares of the pharmacy operator’s stock worth $31,000 after buying an additional 1,280 shares during the period. Institutional investors and hedge funds own 58.59% of the company’s stock.

Insider Activity at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, CFO Manmohan Mahajan acquired 6,000 shares of the business’s stock in a transaction dated Tuesday, April 2nd. The stock was bought at an average price of $19.38 per share, with a total value of $116,280.00. Following the completion of the acquisition, the chief financial officer now owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, Director Inderpal S. Bhandari bought 3,000 shares of the company’s stock in a transaction that occurred on Thursday, April 11th. The stock was bought at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the acquisition, the director now directly owns 3,000 shares of the company’s stock, valued at approximately $54,150. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Manmohan Mahajan acquired 6,000 shares of the company’s stock in a transaction dated Tuesday, April 2nd. The shares were bought at an average cost of $19.38 per share, with a total value of $116,280.00. Following the purchase, the chief financial officer now owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The disclosure for this purchase can be found here. 17.40% of the stock is owned by corporate insiders.

Walgreens Boots Alliance Stock Performance

Shares of WBA stock traded up $0.19 during trading on Tuesday, hitting $16.11. The company’s stock had a trading volume of 8,052,127 shares, compared to its average volume of 13,368,764. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50. The company has a market cap of $13.90 billion, a PE ratio of -2.29, a P/E/G ratio of 1.01 and a beta of 0.78. The business has a fifty day moving average of $17.85 and a 200-day moving average of $20.94. Walgreens Boots Alliance, Inc. has a 52 week low of $14.62 and a 52 week high of $32.89.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last issued its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.82 by $0.38. The company had revenue of $37.05 billion during the quarter, compared to analyst estimates of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. Walgreens Boots Alliance’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same quarter last year, the business posted $1.16 EPS. As a group, research analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.22 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st will be paid a dividend of $0.25 per share. The ex-dividend date is Monday, May 20th. This represents a $1.00 annualized dividend and a yield of 6.21%. Walgreens Boots Alliance’s dividend payout ratio is currently -14.29%.

Analyst Ratings Changes

Several research firms have recently issued reports on WBA. Truist Financial restated a “hold” rating and set a $25.00 price objective on shares of Walgreens Boots Alliance in a report on Monday, April 1st. Morgan Stanley cut their price target on Walgreens Boots Alliance from $16.00 to $13.00 and set an “underweight” rating for the company in a report on Friday. UBS Group lowered their price objective on Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 3rd. TD Cowen reduced their target price on Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating for the company in a research report on Wednesday, April 3rd. Finally, HSBC reiterated a “reduce” rating and set a $20.00 price target (down previously from $27.00) on shares of Walgreens Boots Alliance in a research note on Tuesday, February 20th. Four analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, Walgreens Boots Alliance has an average rating of “Hold” and an average target price of $23.57.

Check Out Our Latest Stock Report on WBA

About Walgreens Boots Alliance

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

See Also

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.